ClinicalTrials.gg
Not yet recruitingNCT07559162AICHI-VRUpdated May 7, 2026

Ai Chi-Based Rehabilitation for Peripheral Unilateral Vestibular Dysfunction

An interventional study of Ai Chi-based exercise program and Home-Based Vestibular Rehabilitation in Unilateral Peripheral Vestibular Hypofunction, Vestibular Disorders and Dizziness, sponsored by Gaziosmanpasa Research and Education Hospital. Not yet recruiting. Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by Gaziosmanpasa Research and Education Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
Female
01

Study summary

This study aims to evaluate the effects of an Ai Chi-based rehabilitation program on balance, dizziness severity, and quality of life in patients with unilateral peripheral vestibular hypofunction. Participants will be randomly assigned to either a control group receiving standard home-based vestibular rehabilitation exercises or an intervention group receiving additional Ai Chi sessions. The intervention will be conducted over a 4-week period with a total of 10 sessions under the supervision of a certified therapist.

Read the detailed description

Unilateral peripheral vestibular hypofunction is a clinical condition characterized by reduced vestibular function due to inner ear or vestibular nerve pathology. It presents with symptoms such as dizziness, imbalance, visual instability, and impaired postural control, significantly affecting functional independence and quality of life. Diagnosis is typically established by the otorhinolaryngology clinic and supported by vestibular function tests such as videonystagmography (VNG) and video head impulse testing (vHIT).

Vestibular rehabilitation is an evidence-based therapeutic approach aimed at promoting central compensation through mechanisms of adaptation, substitution, and habituation. These mechanisms contribute to the improvement of vestibulo-ocular reflex function, postural stability, and overall functional performance.

Ai Chi is an aquatic exercise program derived from Tai Chi and Qi Gong principles, consisting of slow, continuous, and controlled movements coordinated with breathing. The aquatic environment provides unique therapeutic properties such as buoyancy, hydrostatic pressure, and viscosity, allowing safe movement, reducing fall risk, and enhancing proprioceptive and sensory input. These features may support multisensory integration and facilitate central compensation in patients with vestibular dysfunction.

Although aquatic therapy has been increasingly used in rehabilitation, there is limited evidence regarding the effectiveness of Ai Chi specifically in patients with unilateral peripheral vestibular hypofunction. To the best of our knowledge, no randomized controlled study has specifically evaluated the effects of Ai Chi in this patient population.

In this randomized controlled study, participants will be allocated into two groups. Both groups will receive a standardized home-based vestibular rehabilitation program. In addition, the intervention group will participate in supervised Ai Chi sessions conducted in an aquatic environment over a 4-week period, consisting of a total of 10 sessions. All sessions will be delivered by a certified therapist, and adherence will be monitored using exercise logs.

Assessments will be performed at baseline, immediately after the intervention, and during the follow-up period by a blinded evaluator. The findings of this study are expected to contribute to the development of alternative rehabilitation strategies and provide additional evidence for the management of patients with vestibular disorders.

02

Conditions studied

  • Unilateral Peripheral Vestibular Hypofunction
  • Vestibular Disorders
  • Dizziness
  • Vertigo Benign Positional
  • Dizziness and Vertigo
  • Vestibular Function Disorder
03

In context

Dizziness

226 studies on the registry are indexed under Dizziness; 56 are open to participants now.

This study's planned enrollment of 38 is below the median of 43 across 170 interventional studies indexed under Dizziness.

Browse Dizziness studies →

Lead sponsor

Gaziosmanpasa Research and Education Hospital is the lead sponsor of 126 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 70 years
  • Diagnosis of unilateral peripheral vestibular hypofunction
  • Presence of dizziness symptoms for at least 3 months
  • Ability to participate in Ai Chi and aquatic exercise program
  • Berg Balance Scale score ≥21
  • Willingness to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Inability to complete assessment tests and questionnaires
  • Severe systemic disease that may interfere with exercise participation
  • Central vestibular disorders
  • Berg Balance Scale score ≤20
  • Severe visual or hearing impairment
  • Initiation or change of psychiatric medication within the last 3 weeks
  • Severe cardiopulmonary disease
  • to hydrotherapy, including water phobia, behavioral disorders, dyspnea at rest, incontinence, known chlorine allergy, open wounds, acute systemic illness, epilepsy, tracheostomy, permanent drainage devices, immunodeficiency, or known neurological disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    Ai Chi Group

    Participants in this group will receive an Ai Chi-based aquatic exercise program in addition to standard home-based vestibular rehabilitation exercises. The Ai Chi program will be applied over 4 weeks with a total of 10 sessions under the supervision of a certified therapist.

    Behavioral: Ai Chi-based exercise program · Behavioral: Home-Based Vestibular Rehabilitation

  • Active comparator
    Control Group

    Participants in this group will receive standard home-based vestibular rehabilitation exercises without additional Ai Chi intervention.

    Behavioral: Home-Based Vestibular Rehabilitation

Interventions

  • BehavioralAi Chi-based exercise program

    Ai Chi-based exercise program is a structured aquatic therapy approach consisting of slow, continuous, and controlled movements combined with breathing techniques. The program will be conducted in a pool environment over 4 weeks, with a total of 10 sessions delivered as group sessions under the supervision of a certified therapist. The exercises are designed to enhance balance, postural control, proprioceptive input, and multisensory integration, thereby supporting central compensation in patients with vestibular dysfunction.

  • BehavioralHome-Based Vestibular Rehabilitation

    Participants will receive a structured home-based vestibular rehabilitation program including gaze stabilization, head movement, balance, and postural control exercises. The program aims to promote vestibulo-ocular reflex adaptation, improve postural stability, and reduce dizziness-related symptoms. Participants will be instructed to perform the exercises regularly, and adherence will be monitored using exercise logs.

06

What researchers measure

Primary outcomes

  1. Change in balance performance assessed by Berg Balance Scale

    Change in balance performance will be assessed using the Berg Balance Scale (BBS). The BBS consists of 14 items scored from 0 to 4, with a total score ranging from 0 to 56. Higher scores indicate better balance performance. balance performance will be assessed using the Berg Balance Scale in participants receiving Ai Chi-based exercise program in addition to home-based vestibular rehabilitation, compared with participants receiving home-based vestibular rehabilitation alone.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

Secondary outcomes

  1. Change in dizziness-related disability will be assessed using the Dizziness Handicap Inventory (DHI). The DHI consists of 25 items with a total score ranging from 0 to 100. Higher scoredizziness-related disability assessed by Dizziness Handicap Inventory

    Change in dizziness-related disability will be assessed using the Dizziness Handicap Inventory.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

  2. Change in dizziness severity assessed by Vertigo Symptom Scale-Short Form

    Change in vestibular symptoms will be assessed using the Vestibular Symptoms Scale (VSS). The VSS consists of 15 items evaluating the frequency of vestibular symptoms. Each item is scored from 0 to 4, with a total score ranging from 0 to 60. Higher scores indicate more severe symptoms. dizziness severity will be assessed using the Vertigo Symptom Scale-Short Form.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

  3. Change in kinesiophobia assessed by Tampa Kinesiophobia Scale

    Change in kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK). The TSK consists of 17 items scored from 1 to 4, with total scores ranging from 17 to 68. Higher scores indicate greater fear of movement.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

  4. Change in quality of life assessed by Short Form-36

    Change in quality of life will be assessed using the Short Form-36 Health Survey (SF-36). The SF-36 consists of 8 subscales scored from 0 to 100, with higher scores indicating better health status.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

  5. Change in balance confidence assessed by Activities-specific Balance Confidence Scale

    Change in balance confidence will be assessed using the Activities-specific Balance Confidence Scale (ABC). The ABC includes 16 items scored from 0% to 100%, with higher scores indicating greater balance confidence.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

  6. Change in functional mobility assessed by Timed Up and Go Test

    Change in functional mobility will be assessed using the Timed Up and Go Test (TUG). The time required to stand up, walk 3 meters, turn, and sit down is recorded in seconds. Lower times indicate better performance.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

  7. Change in tandem balance performance assessed by tandem stance/walking duration

    Change in dynamic balance will be assessed using tandem walking performance. The duration or number of steps maintained in tandem stance is recorded. Higher performance indicates better balance.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

  8. Change in perceived benefit assessed by Vestibular Rehabilitation Benefit Questionnaire

    Change in perceived benefit will be assessed using the Vestibular Rehabilitation Benefit Questionnaire (VRBQ). The questionnaire evaluates symptom severity and quality of life related to vestibular dysfunction. Raw scores are converted to percentage values ranging from 0 to 100. Higher scores indicate greater symptom severity and poorer quality of life.

    Time frame: Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Kurt EE, Buyukturan B, Buyukturan O, Erdem HR, Tuncay F. Effects of Ai Chi on balance, quality of life, functional mobility, and motor impairment in patients with Parkinson's disease<sup/> Disabil Rehabil. 2018 Apr;40(7):791-797. doi: 10.1080/09638288.2016.1276972. Epub 2017 Jan 13. PubMed 28084851 ↗
  • Covill LG, Utley C, Hochstein C. Comparison of Ai Chi and Impairment-Based Aquatic Therapy for Older Adults With Balance Problems: A Clinical Study. J Geriatr Phys Ther. 2017 Oct/Dec;40(4):204-213. doi: 10.1519/JPT.0000000000000100. PubMed 27490823 ↗
  • Pereira CMM, Pinheiro do Vale JS, de Oliveira WP, Pinto DDS, Cal RVR, de Azevedo YJ, Bahmad F Jr. Aquatic physiotherapy: a vestibular rehabilitation option. Braz J Otorhinolaryngol. 2021 Nov-Dec;87(6):649-654. doi: 10.1016/j.bjorl.2019.12.003. Epub 2020 Jan 13. PubMed 32035856 ↗
  • Elbar O, Tzedek I, Vered E, Shvarth G, Friger M, Melzer I. A water-based training program that includes perturbation exercises improves speed of voluntary stepping in older adults: a randomized controlled cross-over trial. Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):134-40. doi: 10.1016/j.archger.2012.08.003. Epub 2012 Aug 28. PubMed 22951028 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07559162
Responsible party
Yaren Çelik (Physical Medicine and Rehabilitation Resident, Gaziosmanpasa Research and Education Hospital) — Principal investigator
First posted
Apr 30, 2026
Start date
Apr 27, 2026 (estimated)
Primary completion
May 27, 2026 (estimated)
Completion
Jul 27, 2026 (estimated)
Last update
May 7, 2026

Study contacts

Yaren Çelik
Contact
celikyaren9797@gmail.com
+90-507-272-7674

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion